A Study of Brenipatide in Adult Participants With Schizophrenia
for Schizophrenia
32 locations incl. Little Rock
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 55
Code: NCT07410507·Phase 2·Recruiting·Listed Feb 2026
RE:Cognition (Chicago)
Clinical research site in Chicago, Illinois · 820 S DAMEN AVE, CHICAGO, IL 60612-3728 · (608) 821-7200 · Website
As of July 2026, 9 paid clinical trials are recruiting at RE:Cognition (Chicago) in Chicago, Illinois. Active studies at this site cover conditions such as Schizophrenia, Opioid Use Disorder and Alcohol Use Disorder. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at RE:Cognition (Chicago) (9)
A Study of Brenipatide in Participants With Opioid Use Disorder
for Opioid Use Disorder
38 locations incl. Phoenix
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 75
Code: NCT07420283·Phase 2·Recruiting·Listed Feb 2026
A Study of Brenipatide in Participants With Alcohol Use Disorder
for Alcohol Use Disorder
29 locations incl. Scottsdale
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 75
Code: NCT07219953·Phase 3·Recruiting·Listed Oct 2025
A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder
for Alcohol Use Disorder
30 locations incl. Birmingham
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 75
Code: NCT07219966·Phase 3·Recruiting·Listed Oct 2025
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
for Alzheimers Disease
68 locations incl. Birmingham
Sponsor: Hoffmann-La Roche
Sex: All·Age: 50 - 90
Code: NCT07177352·Phase 3·Recruiting·Listed Sep 2025
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
for Alzheimers Disease
35 locations incl. Birmingham
Sponsor: Hoffmann-La Roche
Sex: All·Age: 50 - 90
Code: NCT07169578·Phase 3·Recruiting·Listed Sep 2025
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
for Alzheimer's Disease
25 locations incl. Long Beach
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 60 - 85
Code: NCT06976216·Phase 3·Recruiting·Listed May 2025
Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type
for Agitation
27 locations incl. Anaheim
Sponsor: Suven Life Sciences Limited
Sex: All·Age: 50 - 90
Code: NCT05397639·Phase 3·Recruiting·Listed May 2022
An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome
for Lennox Gastaut Syndrome
12 locations incl. Orange
Sponsor: Epygenix
Sex: All·Age: 2 - 55
Code: NCT05066217·Phase 3·Recruiting·Listed Oct 2021
More research sites in Chicago
- Northwestern University (341 trials)
- University of Chicago (182 trials)
- Rush University Medical Center (151 trials)
- Ann & Robert H. Lurie Children's Hospital of Chicago (113 trials)
- University of Chicago Medical Center (98 trials)
- Northwestern Memorial Hospital (87 trials)
- University of Chicago Comprehensive Cancer Center (87 trials)
- University of Illinois (84 trials)
- University of Illinois at Chicago (72 trials)
- Advocate Illinois Masonic Medical Center (50 trials)
Explore more
Paid clinical trials in Chicago, IL · Illinois clinical trials